Cargando…
Intrathecal Immunoglobulin M Synthesis is an Independent Biomarker for Higher Disease Activity and Severity in Multiple Sclerosis
OBJECTIVE: We aimed to determine in relapsing multiple sclerosis (MS) whether intrathecal synthesis of immunoglobulin (Ig) M and IgG is associated with outcomes reflecting inflammatory activity and chronic worsening. METHODS: We compared cerebrospinal fluid analysis, clinical and magnetic resonance...
Autores principales: | Oechtering, Johanna, Schaedelin, Sabine, Benkert, Pascal, Müller, Stefanie, Achtnichts, Lutz, Vehoff, Jochen, Disanto, Giulio, Findling, Oliver, Fischer‐Barnicol, Bettina, Orleth, Annette, Chan, Andrew, Pot, Caroline, Barakovic, Muhamed, Rahmanzadeh, Reza, Galbusera, Riccardo, Heijnen, Ingmar, Lalive, Patrice H., Wuerfel, Jens, Subramaniam, Suvitha, Aeschbacher, Stefanie, Conen, David, Naegelin, Yvonne, Maceski, Aleksandra, Meier, Stephanie, Berger, Klaus, Wiendl, Heinz, Lincke, Therese, Lieb, Johanna, Yaldizli, Özgür, Sinnecker, Tim, Derfuss, Tobias, Regeniter, Axel, Zecca, Chiara, Gobbi, Claudio, Kappos, Ludwig, Granziera, Cristina, Leppert, David, Kuhle, Jens |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8518907/ https://www.ncbi.nlm.nih.gov/pubmed/34057235 http://dx.doi.org/10.1002/ana.26137 |
Ejemplares similares
-
Intrathecal IgM Synthesis Is Associated with Spinal Cord Manifestation and Neuronal Injury in Early MS
por: Oechtering, Johanna, et al.
Publicado: (2022) -
Brain atrophy measurement over a MRI scanner change in multiple sclerosis
por: Sinnecker, Tim, et al.
Publicado: (2022) -
Association of Brain Atrophy With Disease Progression Independent of Relapse Activity in Patients With Relapsing Multiple Sclerosis
por: Cagol, Alessandro, et al.
Publicado: (2022) -
Serum Neurofilament light: A biomarker of neuronal damage in multiple sclerosis
por: Disanto, Giulio, et al.
Publicado: (2017) -
Combination of teriflunomide and interferon as follow-up therapy
after fingolimod-associated PML
por: Fischer-Barnicol, Bettina, et al.
Publicado: (2020)